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Objective. To compare the equivalent optic nerve head (OHN) parameters obtained with confocal scanning laser ophthalmoscopy
(HRT3) and spectral-domain optical coherence tomography (OCT) in healthy and glaucoma patients. Methods. One hundred
and eighty-two consecutive healthy subjects and 156 patients with open-angle glaucoma were divided into 2 groups according
to intraocular pressure and visual field outcomes. All participants underwent imaging of the ONH with the HRT3 and the Cirrus
OCT. The ONH parameters and the receiver operating characteristic (ROC) curves were compared between both groups. Results.
Mean age did not differ between the normal and glaucoma groups (59.55 ± 9.7 years and 61.05 ± 9.4 years, resp.; 𝑃 = 0.15). Rim
area, average cup-to-disc (C/D) ratio, vertical C/D ratio, and cup volume were different between both instruments (𝑃 < 0.001). All
equivalent ONH parameters, except disc area, were different between both groups (𝑃 < 0.001).The best areas under the ROC curve
were observed for vertical C/D ratio (0.980 for OCT and 0.942 for HRT3; 𝑃 = 0.11). Sensitivities at 95% fixed-specificities of OCT
parameters were higher than those of HRT3. Conclusions. Equivalent ONH parameters of Cirrus OCT and HRT3 are different and
cannot be used interchangeably. ONH parameters measured with OCT yielded a slightly better diagnostic performance.
1. Introduction
Identification of damage to the optic nerve head (ONH) is key
for glaucoma diagnosis. For more than 10 years, the confocal
scanning laser ophthalmoscope Heidelberg Retina Tomo-
graph (HRT, Heidelberg Engineering, Heidelberg, Germany)
has been widely used to evaluate the optic disc morphology
and monitor changes over time [1–10].
On the other hand, since the introduction of optical
coherence tomography (OCT) in 1993 [11, 12], this technique
has been rapidly adopted into clinical practice and is now one
of the main diagnostic methods in ophthalmology. The OCT
is a computer-assisted precision instrument that delineates
cross-sectional anatomy of the retina and provides in vivo
real time images of different structures of the eye. The
performance of OCT has been constantly improved since
its introduction, and the latest versions can generate three-
dimensional images from multiple A-scans acquired on the
optic disc. The cube of data generated from these A-scans
enables a far more extensive evaluation of the peripapillary
area including retinal nerve fiber layer profiles, en face images
(fundus image), and ONH assessment. Diagnostic ability of
OCT for glaucoma diagnosis has been reported in the past
[13–22]. Nevertheless, few studies have compared the ONH
measurements between these devices [23, 24].
The purpose of this study was to compare the equivalent
ONH parameters obtained with Cirrus OCT (Carl Zeiss
Meditec, Dublin, CA) and HRT3 in healthy individuals and
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glaucoma patients as well as evaluate their accuracy for
glaucoma diagnosis.
2. Materials and Methods
The study protocol adhered to the tenets of the Declaration
of Helsinki and was approved by the Clinical Research Ethics
Committee of Arago´n (CEICA).
A total of 350 eyes of 350 subjects were prospectively
preenrolled. Normal eyes were consecutively recruited from
patients referred for refraction that underwent routine exam-
ination without abnormal ocular findings, hospital staff, and
relatives of patients in our hospital.The glaucoma group com-
prised subjects with primary open-angle glaucoma, pseu-
doexfoliative glaucoma, and pigmentary glaucoma. Patients
with glaucoma were recruited consecutively from an ongoing
longitudinal follow-up study at the Miguel Servet University
Hospital. In 4 cases we could not obtain a reliable standard
automated perimetry (SAP) after 3 attempts and in 8 cases
the subject did not complete the visits included in the study
protocol. These 12 subjects were excluded from further anal-
ysis. Finally, 338 eyes of Caucasian origin were included in
the statistical analysis. When both eyes fulfilled the inclusion
criteria, only one eye per subject was randomly selected.
All of them had to meet the following inclusion crite-
ria: best-corrected visual acuity (BCVA) better than 20/30
(Snellen), refractive error less than 5 spherical diopters and
2 diopters of cylinder, transparent ocular media (nuclear
colour/opalescence, cortical or posterior subcapsular lens
opacity < 1) according to the Lens Opacities Classification
System III system [25], and open-anterior chamber angle.
Subjects with previous intraocular surgery, diabetes or other
systemic diseases, history of ocular or neurologic disease,
or current use of a medication that could affect visual field
sensitivity were excluded.
Participants underwent full ophthalmologic examina-
tion: clinical history, best-corrected visual acuity, biomi-
croscopy of anterior segment using a slit lamp, gonioscopy,
Goldmann applanation tonometry, central corneal ultrasonic
pachymetry (OcuScan RxP; Alcon Laboratories Inc., Irvine,
Ca), and ophthalmoscopy of the posterior segment.
At least 2 reliable SAPs were performed to minimize the
learning effect [26–28]. The visual field was evaluated with
a Humphrey Field Analyzer, model 750i (Zeiss Humphrey
Systems, Dublin, CA), by using the 24-2 SITA Standard
strategy. Near addition was added to the subject’s refractive
correction. If fixation losses were higher than 20% or false-
positive or false-negative rates were higher than 15%, the test
was repeated.The subjects completed the perimetrymeasure-
ments prior to any structural test, and each perimetry test
was performed at least 3 days apart to avoid a fatigue effect.
Abnormal SAP results were defined as typical glaucomatous
defects with a pattern standard deviation significantly ele-
vated beyond the 5% level and/or a Glaucoma Hemifield Test
outside normal limits.
The sample was divided into 2 groups according to
the intraocular pressure (IOP) and visual field outcome,
regardless of optic disc appearance. Glaucomatous eyes had
an IOP of greater than 21mmHg and abnormal SAP results.
Topographic analysis of the optic disc was performed
using the HRT3, which provides topographic measurements
of the ONH derived from 16 to 64 optical sections to a
depth of 4mm. The spherical equivalent refractive error of
each eye was adjusted in the dioptric ring of the HRT3.
Magnification errors were corrected by the software based
on keratometric readings. Topographic images were then
obtained through dilated pupils (1% tropicamide eye drops;
Alcon Laboratories Inc., Fort Worth, TX) and analysed with
the Advanced Glaucoma Analysis 3.1 software. All scans had
to have an interscan standard deviation of less than 30 𝜇m.
Themargin of the optic disc was manually traced by the same
glaucoma specialist, who was masked to the patients’ identity
and clinical history, defining the inner edge of Elschnig’s ring
with at least a four-point contour line. All scans had to have
an interscan standard deviation of less than 30𝜇m.The global
stereometric parameters investigated in this study were rim
area, disc area, average cup/disc (C/D) ratio, vertical C/D
ratio, and cup volume.
The equivalent ONH parameters were also measured
using the Cirrus OCT (Optic Disc Cube 200 × 200 scan pro-
tocol; software version 6.2) following a standard procedure
described elsewhere. Left eye data were converted to a right
eye format. All images were acquired with a quality greater
than 6/10. The same operator performed all scans with the
same device.
All the ophthalmic examinations, perimetry tests, and the
topographic analysis of the ONH were performed within 6
weeks of the subject’s date of enrolment into the study.
The statistical analyses were calculated using MedCalc
(version 12; MedCalc software, Mariakerke, Belgium) and
IBM SPSS statistical software (version 22; IBM Corporation,
Somers, NY). All the variables followed a normal distribution
as verified with the Kolmogorov-Smirnov test (K-S of 1
sample). Demographics, HRT3, and OCT parameters were
compared between both groups with the independent 𝑡-test.
The receiver operating characteristic (ROC) curves were
plotted for the ONH parameters acquired with both devices.
The best areas under the ROC curves (AUCs) were also
compared (DeLong method) [29].
3. Results
Table 1 shows the clinical characteristics of the study sample.
Mean age in the normal group (182 eyes) was 59.55 ± 9.71
years, while mean age in the glaucoma group (156 eyes)
was 61.05 ± 9.43 years (𝑃 = 0.15). There were significant
differences (𝑃 < 0.001) in mean IOP, best-corrected visual
acuity, central corneal thickness, mean deviation of SAP,
pattern standard deviation of SAP, and the visual field index
(VFI) of SAP between both groups.
Disc area measured with Cirrus OCT did not differ
between the groups (𝑃 = 0.10). Nevertheless, HRT3 showed
significant differences for disc area between the normal and
glaucoma groups (𝑃 < 0.001). Rim area, average C/D ratio,
vertical C/D ratio, and cup volume of both Cirrus OCT and
HRT3 were different between both groups (𝑃 < 0.001).
Table 2 shows the equivalent ONH parameters measured
with Cirrus OCT and HRT3 in the normal and glaucoma
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Table 1: Clinical characteristics of the sample.
Normal Glaucoma
𝑃
Mean SD Mean SD
Age (yrs) 59.55 9.7 61.05 9.4 0.152∗
BCVA (Snellen) 0.93 0.1 0.82 0.2 <0.001∗
IOP (mmHg) 17.10 2.3 26.68 5.6 <0.001∗
Pachymetry (𝜇m) 554.63 33.7 535.30 37.7 0.001∗
MD SAP (dB) −0.38 0.9 −6.64 6.0 <0.001∗
PSD SAP 1.42 0.3 6.03 3.8 <0.001∗
VFI SAP 99.55 0.7 83.97 17.2 <0.001∗
Gender (male/female) 57/125 68/88 0.031∗∗
𝑁 182 156
∗Student’s t-test; ∗∗chi-square test; BCVA: best-corrected visual acuity; IOP: intraocular pressure; MD: mean deviation; PSD: pattern standard deviation; SAP:
standard automated perimetry; VFI: visual field index; SD: standard deviation;𝑁: number of cases.
Table 2: Comparison of the equivalent ONH parameters measured with Cirrus OCT and HRT3 in the normal and glaucoma groups.
Cirrus OCT HRT3
𝑃
∗
Min Max Mean SD Min Max Mean SD
Normal group
Rim area 0.87 2.33 1.49 0.29 0.86 2.59 1.50 0.32 0.87
Disc area 1.07 2.67 1.93 0.32 0.89 3.43 1.87 0.44 0.17
Average C/D 0.06 0.77 0.42 0.17 0.00 0.58 0.19 0.13 <0.001
Vertical C/D 0.06 0.74 0.40 0.16 0.00 0.74 0.26 0.22 <0.001
Cup volume 0.00 0.78 0.10 0.13 0.00 0.48 0.07 0.09 0.050
Glaucoma group
Rim area 0.23 1.45 0.80 0.25 0.20 2.09 1.06 0.34 <0.001
Disc area 1.45 2.53 2.02 0.26 1.30 3.82 2.11 0.41 0.013
Average C/D 0.53 0.9 0.76 0.09 0.00 0.87 0.49 0.18 <0.001
Vertical C/D 0.54 0.89 0.74 0.09 0.00 0.95 0.66 0.21 <0.001
Cup volume 0.02 0.97 0.49 0.23 0.00 1.41 0.31 0.22 <0.001
∗Student’s t-test.
C/D: cup-to-disc ratio; Min: minimum; Max: maximum; SD: standard deviation.
groups. In the normal group, average and vertical C/D ratios
were different between Cirrus OCT and HRT3, while in the
glaucoma group, all the equivalent ONH parameters were
different (𝑃 < 0.001).
The largest AUCs obtained with Cirrus OCT (Table 3)
were observed for vertical C/D ratio (0.980; 𝑃 < 0.001) and
rim area (0.966; 𝑃 < 0.001). All AUCs of Cirrus OCT were
above 0.92, except disc area. ForHRT3, the largest AUCswere
observed for vertical C/D ratio (0.942; 𝑃 < 0.001) and rim
area (0.905; 𝑃 < 0.001). The differences of the AUCs between
both devices were tested by theDeLongmethod (Table 4). No
differences were found for the best ONHparameters (vertical
C/D ratio) to discriminate between healthy and glaucoma
patients (𝑃 = 0.11).
Sensitivities of all ONH parameters ranged from 79% to
98% at 86% to 99% specificities (Table 5).The best sensitivity-
specificity balance was observed for vertical C/D ratio in
both devices: 94%-93% for Cirrus OCT and 90%–94% for
HRT3. The rim area (Cirrus OCT) and vertical C/D ratio
(HRT3) yielded the highest sensitivities (96.1%) at 85% fixed-
specificity, whereas the sensitivities were 80.7% and 91%,
respectively, at 95% fixed-specificity. Overall, sensitivities at
95% fixed-specificities of the Cirrus OCT parameters were
higher than those of HRT3.
4. Discussion
This study was aimed at comparing the equivalent ONH
parameters obtained by Cirrus OCT and HRT3 (rim area,
disc area, average C/D ratio, vertical C/D ratio, and cup
volume) between healthy and glaucoma patients. We found
significant differences for average C/D ratio, vertical C/D
ratio, and cup volume in the normal group and for all
equivalent ONH parameters in the glaucoma group between
both instruments.
Few articles have compared the ONH parameters
between Cirrus OCT and HRT3. Sato et al. [23] performed
a similar study by comparing ONH parameters from
96 glaucoma patients and 21 healthy subjects. They also
found significant differences (𝑃 < 0.001) in all the studied
parameters, although this analysis was performed on the
total sample, not for subgroups.
The software of the HRT3 determines a reference plane
parallel to the retina surface. The standard reference plane is
located 50 𝜇m posterior to the temporal ONH margin. The
tissue above the reference plane is considered as “rim” while
the structure below is considered as “cup.” Although the level
of the reference plane should not affect the measurement
of the disc area, its position has a direct impact on the
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Table 3: Areas under the ROC curve of the optic nerve head parameters to discriminate between healthy and glaucoma patients.
AUC SE 𝑃 CI 95%
Inferior limit Superior limit
Cirrus OCT
Rim area 0.966 0.02 <0.001 0.936 0.995
Disc area 0.584 0.05 0.120 0.481 0.688
Average C/D 0.961 0.02 <0.001 0.932 0.991
Vertical C/D 0.980 0.01 <0.001 0.960 0.999
Cup volume 0.924 0.03 <0.001 0.873 0.975
HRT3
Rim area 0.905 0.03 <0.001 0.849 0.962
Disc area 0.642 0.05 0.009 0.544 0.740
Average C/D 0.887 0.03 <0.001 0.824 0.950
Vertical C/D 0.942 0.03 <0.001 0.888 0.995
Cup volume 0.902 0.03 <0.001 0.846 0.958
C/D: cup-to-disc ratio; AUC: area under the receiver operating characteristic curve; CI: confidence interval; SD: standard error.
Table 4: Comparison of the best areas under the ROC curve of the equivalent optic nerve head parameters between Cirrus OCT and HRT3
(DeLong method).
Cirrus OCT
Rim area Vertical C/D ratio Cup volume
HRT3
Rim area 0.015 0.003 0.318
Vertical C/D ratio 0.363 0.114 0.489
Cup volume 0.017 0.001 0.233
C/D: cup-to-disc.
Table 5: Best sensitivity-specificity balance of Cirrus OCT and HRT3 to discriminate between normal and glaucomatous eyes.
Optimal
cut-off point
Sensitivity
(%)
Sensitivity
95% CI
Specificity
(%)
Specificity
95% CI
Sensitivity at fixed specificity
Specificity 85% Specificity 95%
Cirrus OCT
Rim area ≤1.2 98.1 90.1–100 86.3 76.2–96.2 96.1 80.7
Average C/D >0.67 83.3 70.7–92.1 98.9 92.6–100 85.2 84.6
Vertical C/D >0.59 94.2 84.6–98.8 93.4 84.7–97.7 77.5 86.5
Cup volume >0.263 87.1 75.1–94.6 89.0 79.5–95.1 91 72.4
HRT3
Rim area ≤1.16 79.4 66.5–89.4 90.1 81.2–96.1 83.3 68.5
Average C/D >0.39 86.5 74.7–94.5 94.5 86.6–98.5 90.3 80.7
Vertical C/D >0.55 90.3 79.7–96.9 94.5 86.6–98.5 96.1 91
Cup volume >0.14 83.3 70.7–92.1 86.3 76.2–93.2 81.4 59.6
C/D: cup-to-disc ratio; CI: confidence interval.
calculation of the rim and cup areas. OCT measurement
does not depend on reference planes and does not require
prior manual outlining of disc boundaries, reducing the
dependency on operator skill. Additionally, in Cirrus OCT,
the disc edge is determined by the termination of Bruch’s
membrane; thus, the measurement of the rim and cup areas
corresponds with the actual anatomy in the same plane as the
optic disc. HRT3 does not take into account the inclination of
the optical disc as it acquires the images in horizontal planes,
leading to a worse performance in tilted discs compared to
OCT.
Other authors have evaluated the differences for ONH
parameters obtained by Stratus OCT and HRT [30–32].
Generally, it is accepted that Stratus OCT tended to measure
larger areas of the disc than HRT. In our work we did
not observe the same trend: disc area was 1.93mm2 for
Cirrus OCT and 1.87mm2 for HRT3 (𝑃 = 0.17) in healthy
individuals. In the glaucoma group, disc area was 2.02mm2
for Cirrus OCT and 2.11mm2 for HRT3 (𝑃 = 0.01). By
contrast, in the work of Sato et al. [23] disc areas with
Cirrus OCT were smaller than those obtained with the
HRT (1.97mm2 versus 2.27mm2). They included a small
sample in the normal group (𝑛 = 21) and performed the
statistical analysis in the whole sample, including normal
and glaucomatous eyes. Larger samples usually lead to more
precise estimates.
Moghimi et al. [24] also studied the relationship between
the ONH parameters measured with Cirrus OCT and HRT3.
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This work included 13 healthy individuals, 21 glaucoma
suspects, and 37 patients with established glaucoma. They
reported thatHRT3 tended to overestimate disc and rim areas
compared to Cirrus OCT.
Regarding the ONH parameters we found statistical
differences for all the ONH parameters, except disc area,
between the normal and glaucoma groups for both devices.
These findings are consistent with previous studies [33–35].
Mwanza et al. [35] also found differences for all ONH param-
eters, except for disc area. They included 73 patients with
glaucoma (31 mild, 14 moderate, and 28 severe glaucomas)
and 146 healthy patients. They found AUC values ranging
from 0.901 to 0.963 for all parameters, except disc area. They
also observed, in agreement with our findings, that vertical
C/D ratio was one of the best parameters to discriminate
between healthy and glaucomatous eyes.
ThebestHRT3parameter to differentiate between healthy
and glaucoma patients was also vertical C/D ratio (0.942). de
Leo´n-Ortega et al. [36] found a similar result, although their
AUC value was lower (0.861). Obviously, the severity of visual
field loss has an important influence on imaging instrument
sensitivity [27, 37]. More severe disease is associated with
increased sensitivity. In our study, most glaucomatous eyes
had mild to moderate visual field defects, according to the
Hodapp-Parrish-Anderson score [38].
The quality of the data obtained by the imaging devices is
influenced by the media opacity, retinal pigment epithelium
status, instrument variability, and positioning and centering
of the images. Our sample had transparent ocular media,
but this condition is not always possible in clinical practice.
Clinicians should take into account that the accuracy of the
measurements is related to the quality of the images.
5. Conclusions
ONH parameters of Cirrus OCT and HRT3 should not
be used interchangeably. Optic disc assessment using Cir-
rus OCT showed a slightly better diagnostic performance
than HRT3 to discriminate between healthy and glaucoma
patients.
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